Publication date: 2026 Source: Disease and Therapeutics, Volume 2 Author(s): Jarrett J. Adams, Levi L. Blazer, Gang Chen, Jacky Chung, Evan Mallette, Alexander U. Singer, Sanjeev K. Mendiratta, Sanjay Bandyopadhyay, Arun K. Singh, Pankaj Kalita, Minoo Karimi, Lia Cardarelli, C. Ronald Geyer, Stephen W. Michnick, Sachdev S. Sidhu
A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo. // Disease and Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S3050999826000034?dgcid=rss_sd_all
A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo. Disease and Therapeutics. https://www.sciencedirect.com/science/article/pii/S3050999826000034?dgcid=rss_sd_all
“A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo.” Disease and Therapeutics.
@article{article43438,
title = {A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo},
journal = {Disease and Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S3050999826000034?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez